V1 and V2 vasopressin receptors — Drug Target

All drugs that target V1 and V2 vasopressin receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Vasopressor agent

Phase 3 pipeline (1)

• Administration of AVP · Assistance Publique - Hôpitaux de Paris · Vasopressor agent · Critical Care / Intensive Care Medicine
  AVP is an arginine vasopressin analog that acts as a vasopressor agent to increase blood pressure and peripheral vascular resistance.